Smart. Sharp. Funny. Fearless.
Friday, October 20, 2017
Charles Ornstein, ProPublica, and Katie Thomas, The New York Times
opioids

Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers

At a time when the United States is in the grip of an opioid epidemic, many insurers are limiting access to pain medications that carry a lower risk of addiction or dependence, even as they provide comparatively easy access to generic opioid medications.

September 18, 2017

Generic Drug Prices Are Declining, But Many Consumers Aren’t Benefiting

Amid the public fury over the escalating costs of brand-name medications, the prices of generic drugs have been falling, raising fears about the profitability of major generic manufacturers. Last week, Teva Pharmaceuticals reported that it had missed analysts’ earnings estimates in the second quarter and planned to lay off 7,000 workers.

August 10, 2017

Take The Generic Drug, Patients Are Told — Unless Insurers Say No

Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more. Adderall XR, a drug to treat attention-deficit hyperactivity disorder, is a case in point.

August 7, 2017